Pfizer (NYSE: PFE) reported Q1 EPS of $0.75, $0.03 better than the analyst estimate of $0.72. Revenue for the quarter came in at $14.5 billion versus the consensus estimate of $13.84 billion.

GUIDANCE:

Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.96.

For earnings history and earnings-related data on Pfizer (PFE) click here.